Anzeige
Mehr »
Login
Sonntag, 05.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
InnoCan Pharma: Multi-Milliarden-Wert in diesem Pennystock?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Übersicht Suchergebnisse zum Thema NASDAQ

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
SaStock Market Crash Warning: Don't Get Caught Holding These 3 Nasdaq Stocks2
SaForget the Nasdaq -- Invest in This Unstoppable ETF Instead1
SaStock Market Crash Alert: 7 Must-Buy Nasdaq Stocks When Prices Plunge2
Sa4 Colossal Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market3
FrNewbury Street Acquisition Corporation Announces Receipt of Nasdaq Letter89Boston, MA, May 03, 2024 (GLOBE NEWSWIRE) -- Newbury Street Acquisition Corporation (NASDAQ: NBST, the "Company") announced today that it received a letter dated April 24, 2024, from the Listing Qualifications...
► Artikel lesen
FrFerrovial Completes Regulatory Review Process for Nasdaq Listing79Listing marks intent to expand already-robust presence in North America AMSTERDAM, May 3, 2024 /PRNewswire/ -- Ferrovial SE ("Ferrovial" or the "Company"), one of the world's leading infrastructure...
► Artikel lesen
FrDelcath Systems, Inc.: Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)66NEW YORK, May 3, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH) (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary and metastatic cancers...
► Artikel lesen
FrPraxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)37BOSTON, May 03, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies...
► Artikel lesen
FrJayud Global Logistics receives non-compliance notice from Nasdaq1
FrQuantum provides updated plan to Nasdaq1
FrORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)41SOUTH SAN FRANCISCO and SAN DIEGO, May 03, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms...
► Artikel lesen
FrNeuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)40MALVERN, Pa., May 03, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
► Artikel lesen
FrJayud Global Logistics Ltd: Jayud Global Logistics Receives Nasdaq Notification of Non-Compliance with Listing Rule 5550(b)85SHENZHEN, China, May 03, 2024 (GLOBE NEWSWIRE) -- Jayud Global Logistics Limited (NASDAQ: JYD) ("Jayud" or the "Company"), a leading end-to-end supply chain solution provider based in Shenzhen, specializing...
► Artikel lesen
FrDianthus Therapeutics, Inc.: Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)45NEW YORK and WALTHAM, Mass., May 03, 2024 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. ("Dianthus"), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody...
► Artikel lesen
FrMersana Therapeutics, Inc.: Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)38CAMBRIDGE, Mass., May 03, 2024 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug...
► Artikel lesen
FrNASDAQ, INC. - 8-K, Current Report2
FrMural Oncology, Inc.: Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)32WALTHAM, Mass and DUBLIN, May 03, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company leveraging its core competencies in immune cell modulation and...
► Artikel lesen
FrArcutis Biotherapeutics, Inc.: Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)128WESTLAKE VILLAGE, Calif., May 03, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in...
► Artikel lesen
FrVerve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)45BOSTON, May 03, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing...
► Artikel lesen
FrVor Biopharma: Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)49CAMBRIDGE, Mass., May 03, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that, effective as of May 1, 2024, the Compensation...
► Artikel lesen
Seite:  Weiter >>